临床预约用血审批制的建立及成效分析

Establishment and effect analysis of approval system for clinical appointment of blood usage

目的评估临床预约用血审批制对临床用血管理的影响。方法统计2014-2017年人均用血量,手术台均用血量,急诊均次用血量,不合理用血比例和输血不良反应比例,运用SPSS16.0分析2015年1月1日实施临床预约用血审批制后,2015-2017年与2014年相比人均用血量,手术台均用血量,急诊均次用血量,不合理用血比例和输血不良反应比例的差异,P<0.05表示差异显著。结果与2014年相比,2015-2017年人均用血量,急诊均次用血量和输血不合理比例明显下降,其中2015-2017年人均用血量下降率分别为2.0%,5.2%和3.4%,急诊均次用血量下降率分别为14.5%,7.1%和9.2%,输血不合理比例下降率分别为21.4%,78.6%和72.7%。2016年和2017年手术台均用血量增长显著, 2015-2017年输血不良反应比例无显著差异。结论临床预约用血审批制使临床用血流程更加精细规范,保证科学合理用血,有效提高临床用血质量管理和工作效率。

Objective To evaluate the impact of approval system for clinical appointment of blood usage on the clinical blood management. Methods The approval system for clinical appointment of blood usage was implemented on January 1, 2015, and the data related to per capita consumption of blood, the average blood consumption of each operation, the blood consumption for each emergency, the proportion of unnecessary transfusions and the proportion of adverse reactions to blood transfusion between 2014(before application of the the approval system) and 2015 to 2017(three years after application of the the approval system) were analyzed statistically using SPSS16.0. Results Compared with 2014, the per capita consumption of blood, the blood consumption for each emergency and the proportion of unnecessary transfusions decreased significantly from 2015 to 2017. In 2016 and 2017, the average blood consumption of each operation increased significantly. There was no significant difference in the proportion of adverse reactions to blood transfusion from 2015 to 2017. Conclusion The approval system for clinical appointment of blood usage could smooth the flow of clinical use of blood, ensure the scientific and rational use of blood, also enhance the management of it.